Celgene Can’t ‘Guess’ How Rival Mylan Operates, Judge Says – Law360
Celgene’s arguing attorney, Ellyde R. Thompson of Quinn Emanuel Urquhart & Sullivan … Hetero Labs to resolve a patent infringement action over the drug.
In: PATENT NEWS
Celgene’s arguing attorney, Ellyde R. Thompson of Quinn Emanuel Urquhart & Sullivan … Hetero Labs to resolve a patent infringement action over the drug.
In: PATENT NEWS
The Federal Circuit issued its “venue manipulation” ruling in patent suits … was an intervening change in controlling law that applies to this case.
In: PATENT NEWS
PTAB Strategies and Insights – August 2021: For Partial Design Patents and Utility Patents Alike, Reliance on Objective Indicia Requires Evidence of a Nexus to the Unique Claimed Features JD Supra
In: PATENT NEWS
(Reuters) – The director of the U.S. Patent and Trademark Office has enough … the law was passed, Bryson said earlier trademark laws still gave the PTO …
In: PATENT NEWS
After the PTO denied some of his patent applications, Mr. Hyatt elected to … legislative history, relevant case law and similarly phrased statutes to …
In: PATENT NEWS
The IAM Patent 1000 is a standalone publication that identifies individual and firm expertise in all major areas of patent law and practice.
In: PATENT NEWS
Absent Explicit Statutory Language? The American Rule Still Applies JD Supra
In: PATENT NEWS
This Practice Note provides an overview of the principal categories of intellectual property (IP) under US law and related practice considerations.
In: PATENT NEWS
… that a number of companies are flouting Section 337 of the Tariff Act of 1930, a law that prohibits imports of products that infringe U.S. patents.
In: PATENT NEWS
As part of that agreement, ECHL represented that (1) it had the right, … was one of contractual interpretation rather than intellectual property law.
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION